Skip to content

AxiumTM QC-8-20-3DRecalls & reported problems

Micro Therapeutics, Inc. · COIL QC-8-20-3D V04 AXIUM · Class 2 · Implant

All models of AxiumTM (139)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00847536030084), received between Mar 23, 2020 and Oct 25, 2023 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Break” (2 reports).

2 other recalls cover devices cleared under the same FDA submission (K081465); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break2
  • Detachment of Device or Device Component1
  • Physical Resistance/Sticking1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 25, 2023Break; Physical Resistance/Sticking; Break; Physical Resistance/Sticking

    ADDITIONAL INFORMATION RECEIVED REPORTED THERE WAS POTENTIALLY DAMAGE TO THE AXIUM COIL. THE PHYSICIAN SEEMED TO THINK THERE WAS A PART OF THE AXIUM COIL LEFT IN THE COILING CATHETER WHICH CAUSED THE FOLLOWING HYDROGEL COIL TO GET STUCK. CATHETER NEEDS TO BE INSPECTED TO CONFIRM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18007301 ↗
  • MalfunctionJul 28, 2021Detachment of Device or Device Component; Detachment of Device or Device Component

    ADDITIONAL INFORMATION RECEIVED INDICATED THE PROCEDURE WAS COMPLETED BY USING OTHER AXIUM COILS AFTER RETRIEVING THE DETACHED COIL FROM THE VESSEL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12243522 ↗
  • MalfunctionMar 23, 2020Break; Break

    MEDTRONIC RECEIVED A REPORT THAT THE AXIUM COIL SEPARATED IN THE CATHETER DURING DELIVERY. THE CATHETER WITH THE COIL WAS REMOVED FROM THE PATIENT, AND REPLACEMENT DEVICES WERE USED TO COMPLETE THE PROCEDURE. IT WAS INDICATED THAT ALL DEVICES WERE PREPARED AS PER THE INSTRUCTIONS FOR USE (IFU), AND NO PATIENT SYMPTOMS OR FURTHER COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. THE PATIENT WAS UNDERGOING SURGERY FOR TREATMENT OF A SACCULAR, UNRUPTURED ANEURYSM IN THE LEFT INTERNAL CAROTID ARTERY WITH A MAX DIAMETER OF 8MM AND A 4MM NECK DIAMETER. IT WAS NOTED THE PATIENT'S BLOOD FLOW WAS NORMAL AND VESSEL TORTUOSITY WAS MODERATE. ANCILLARY DEVICES INCLUDE A FUBUKI GUIDE CATHETER, AND HEADWAY 17 MICROCATHETER.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 9865395 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K081465. One submission often covers many models, so check the product and lot details in each record.

  • Z-0873-2012 · Mar 1, 2010 · Terminated
    Axium Detachable Coil System QC-2-1-Helix The ev3 Axium Detachable Coil System is indicated for the endovascular embolization of intracranial aneurysms and other neurovascular ab
  • Z-0874-2012 · Mar 1, 2010 · Terminated
    Axium Detachable Coil System QC-7-30-Helix The ev3 Axium Detachable Coil System is indicated for the endovascular embolization of intracranial aneurysms and other neurovascular a

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page